{"id":"W4309014865","doi":"10.1093/neuonc/noac209.401","title":"DDDR-36. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"University of Texas MD Anderson Cancer Center","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Clinical trial; Dexamethasone; Oncology; Refractory (planetary science); Adverse effect; Radiosurgery; PTEN; Gastroenterology; Surgery; Radiation therapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422495,0.0001973767,0.0005877833,0.000242954,0.0002721082,0.0004036429,0.0002468346,0.0003811696,0.0007977441],"category_scores_gemma":[0.00054964,0.000112331,0.0003970588,0.0004777396,0.0002616409,0.000230007,0.0003325025,0.0005327881,0.0001651486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006378712,"about_ca_system_score_gemma":0.0006449786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002925,"about_ca_topic_score_gemma":0.004007673,"domain_scores_codex":[0.9997337,0.00008916669,0.00002670143,0.00005289107,0.00003075444,0.00006671371],"domain_scores_gemma":[0.9995716,0.00004665458,0.0001216,0.00001947125,0.00002221432,0.0002185146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04153117,0.003644925,0.8755847,0.0001161466,0.0004140683,0.002887954,0.0003247416,0.0007511897,0.0163692,0.0001283541,0.001779163,0.05646845],"study_design_scores_gemma":[0.005251809,0.05605531,0.9251889,0.00004352339,0.000425504,0.004591251,0.0002511788,0.001710588,0.002421962,0.0002257349,0.003796348,0.00003799216],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991769,0.0002959085,0.00002778877,0.00006163098,0.000006883236,0.00002042546,0.00008855271,0.000007984365,0.000313858],"genre_scores_gemma":[0.9993476,0.00009699541,0.00006599912,0.00009583165,0.00001242557,0.00001884611,0.0002528217,0.00000208799,0.0001074966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002925,"threshold_uncertainty_score":0.005815923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02497113202779076,"score_gpt":0.3246248795563418,"score_spread":0.2996537475285511,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}